Swecure is a Swedish biotechnology company developing the world’s first preventive treatment for allergy. Current treatments attempt to control the symptoms of allergic reactions, but do not eliminate the conditions. Swecure address the root causes of the problem. We have identified a Superantigen – a bacterial protein, with a unique ability to activate an infant’s immune system and stop allergies before they develop.
Co-founded and organized with Xavier Duportet (MIT – INRIA Constraint Groups), Hello Tomorrow Challenge is a unique event to empower young european innovators (more than 1200 startups selected).
Executive Business Accelerator – Jury of the Hello Tomorrow Challenge, 17 – 18 April 2014.
Swecure – HTC Challenge